Olmesartan may be associated with higher rate of enteropathy versus other ARBs | ACP Gastroenterology Monthly
The association appeared to be stronger among patients ages 65 years and older, those who were treated for more than a year, and those with higher cumulative olmesartan doses.
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
Misoprostol may help treat obscure GI bleeding in patients taking aspirin, NSAIDs | ACP Gastroenterology Monthly
Complete healing of small-bowel ulcers and erosions, as assessed by video-capsule endoscopy, was significantly more common among patients receiving misoprostol than those randomized to placebo, a small British study found.